Beruflich Dokumente
Kultur Dokumente
Technologies
RP-HPLC Analysis of an
AlkaloidMethyllycaconitine from Mutagenic
Delphinium malabaricum (Huth) Munz
Firdose R. Kolar, Swaroopa R. Ghatge, Nilesh V. Pawar & Ghansham B. Dixit
To cite this article: Firdose R. Kolar, Swaroopa R. Ghatge, Nilesh V. Pawar & Ghansham B.
Dixit (2015) RP-HPLC Analysis of an AlkaloidMethyllycaconitine from Mutagenic Delphinium
malabaricum (Huth) Munz, Journal of Liquid Chromatography & Related Technologies, 38:20,
1802-1807, DOI: 10.1080/10826076.2015.1110706
To link to this article: http://dx.doi.org/10.1080/10826076.2015.1110706
Article views: 26
Laboratory of Cytogenetics and Plant Breeding, Department of Botany, Shivaji University, Kolhapur, India
A systematic search of some phytochemicals in Delphinium malabaricum will be undertaken to evaluate the therapeutic quality of
D. malabaricum. The populations of D. malabaricum were subjected to analysis of alkaloids by Reversed phase HPLC technique.
Among the various alkaloids present in Delphinium species methyllycaconitine is a principle alkaloid. Therefore, the populations of
D. malabaricum were assessed for Methyllycaconitine (MLA) content in the mutants and their control. The results revealed that the
MLA content was highest with 0.01% concentration of EMS (0.78 mg/g plant material) as compared to the control (0.76 mg/g plant
material). The concentration of MLA decreased with an increase in dose/concentration of the mutagens. Less concentration of MLA in
the roots of D. malabaricum indicates that it is less toxic and a further decrease in concentration after mutagenic treatment minimizes
its toxic effects. As these populations are growing in the same environmental and edaphic conditions, observed variability can be
related to genetic makeup altered due to mutation. The RP-HPLC analysis results could form the basis of a more detailed study of
root alkaloids and any marked similarity/dissimilarity in their alkaloid pattern may draw reasonable conclusions of the difference
between the mutants and the parent cultivar.
Keywords: alkaloids, Delphinium malabaricum, methyllycaconitine, mutation, RP-HPLC, TLC
Introduction
Experimental
Induction of Mutation
1803
centrifuged at 10,000 rpm for 15 min and the supernatant was
filtered through Whatman filter paper No.1 using Buchner
funnel. All these extracts were stored at 4C in air tight
containers for further use.
Sample Preparation
TotalX Z Y
Screening of Alkaloids by Thin Layer Chromatography
Thus, the crude extract of alkaloids obtained was weighed and
dissolved in a known volume of ethanol and was used for
TLC. For this technique precoated TLC aluminum sheets
(20 20 cm Silica gel 60 F254) were used. The alkaloid spots
were separated using the solvent mixture chloroform and methanol (15:1). The color and Rf values of the separated alkaloids
were recorded both under ultraviolet (UV 254 nm) and visible
light after spraying with Dragendorffs reagent.
RP-HPLC Analysis of AlkaloidMethyllycaconitine
For the RPHPLC analysis of alkaloid Methyllycaconitine in D.
malabaricum and its mutant populations, mutant rhizomes
obtained from treatments of all the concentrations of mutagens
from M3 generation along with control were selected.
Extract Preparation
Rhizomes of D. malabaricum from different concentrations of all
the mutagenic treatments including control were obtained from
the field and washed thoroughly under tap water and then rinsed
with double-distilled water. Rhizomes were blotted to dry with
tissue towel and dried in an oven at 60C. After drying, rhizomes
were crushed separately and finely ground to a powder in an
electric blender. The one gram powder of rhizome from each
treatment was extracted using 10 mL ethanol with continuous
shaking on a rotary shaker for 24 hr. The mixture was then
1804
Results
F. R. Kolar et al.
Fig. 2. Reverse-phase HPLC chromatograms of alkaloid profiles of Delphinium malabaricum: a: Chromatogram of MLA (125 ppm); b:
Control; c: 0.01% EMS; d: 0.05% EMS; e: 0.10% EMS; f: 0.15% EMS; g: 0.20% EMS; h: 0.25% EMS; i: 0.30% EMS; j: 0.01% SA.
1805
Fig. 3. Reverse-phase HPLC chromatograms of alkaloid profiles of Delphinium malabaricum: a: 0.05% SA; b: 0.10% SA; c: 0.15% SA;
d: 0.20% SA; e: 0.25% SA; f: 0.30% SA; g: 5kR gamma rays; h: 10kR gamma rays; i: 15kR gamma rays; j: 20kR gamma rays.
1806
F. R. Kolar et al.
Control
EMS
SA
Gamma
Rays
0.01%
0.05%
0.10%
0.15%
0.20%
0.25%
0.30%
0.01%
0.05%
0.10%
0.15%
0.20%
0.25%
0.30%
5 kR
11.91
12.21
12.02
11.97
12.06
12.15
11.99
12.11
11.84
11.83
11.94
11.75
12.02
12.10
12.03
11.83
0.765
0.320
0.397
0.788
0.320
0.272
0.200
0.196
0.365
0.492
0.430
0.370
0.363
0.359
0.239
0.266
0.076
0.032
0.039
0.078
0.032
0.027
0.020
0.019
0.036
0.049
0.043
0.037
0.036
0.035
0.023
0.026
10 kR
15 kR
20 kR
11.94
12.00
12.08
0.328
0.397
0.312
0.032
0.039
0.031
1
Results are expressed as milligram of fraction equivalent (Methyllycaconitine)
per gram of sample.
2
Percentage Relative % of total concentration.
Discussion
Delphinium species are well known as a source of alkaloids of
pharmaceutical importance. Alkaloids, as a rule, do not occur
singly in plants. The plant usually produces a series of alkaloids,
which may differ only slightly in physical and chemical characters. In the plants, alkaloids may be systemic, that is, distributed
throughout, or restricted to specific organs like roots (Aconite,
Belladona), rhizomes and roots (Ipecac, Hydrastis), stem barks
(Cinchona, Pomegranate), leaves (Hyoscyamus, Belladona),
fruits (Pepper, Conium), or seeds (Nuxvomica, Areca).[10] In
present study, the analysis of alkaloids using thin layer chromatographic technique showed the presence of various alkaloids in
D. malabaricum. TLC is the principle technique of chromatography. Therefore, further analysis by higher techniques such
as high performance liquid chromatography (HPLC) or NMR
(nuclear magnetic resonance) spectroscopy for clear identification of alkaloids present in D. malabaricum is necessary.
Alkaloid synthesis pathways are highly regulated and involve
controls at the cell, tissue, plant, and environmental levels.[11]
Benn and May[12] indicated that larkspur alkaloids are synthesized
in roots, but little is known about further synthesis and translocation. Nicotinic acetylcholine receptors (nAchRs) are a family
of ligand gated ion channels that are widely distributed in the
human brain.[13] These receptors have numerous receptor subtypes
composed of combinations of a2-7, a9-10, and b2-4subunits.[14,15]
This subunit composition represents a major factor in determining
pharmacological and functional properties of these receptors.
NAchRs are involved in a number of physiological and behavioral
conditions; hence, there is a pressing need for subtype selective
agonists and antagonists to elucidate the biological roles of these
receptors and to provide candidates for drug discovery. The a7
nAChR subtype is among the most prevalent in the brain and
has been implicated as playing a key role in conditions such as
schizophrenia, Alzheimers disease, and epilepsy. Methyllycaconitine (MLA) is one of only a few compounds (including the peptide toxins, a-bungarotoxin, and a-conotoxin) that bind with high
affinity and selectivity to the a7nAChR. MLA is therefore a prime
lead compound for development of new therapies targeting the
a7nAChR. Based on its unique interaction with nAChRs, methyllycaconitine is an inspiration source for medicinal chemistry. We
have therefore embarked on a program to isolate MLA from D.
malabaricum. Methyllycaconitine (MLA) is one member of a
larger family of diterpene alkaloids, isolated from Delphinium
and Aconitum species of plants that have been known as sources
Conclusions
The Delphinium species contain a number of alkaloids of pharmaceutical importance in addition to the alkaloid methyllycaconitine
that need to be assessed when considering the therapeutic value of
the plant. The extremely potent and selective nicotinic acetylcholine receptor antagonist methyllycaconitine alkaloids are finding
increasing use as neurochemical probes and as targets for structure-activity relationship statistics. In this work, an assay procedure for MLA, which utilizes reverse-phase HPLC with UV
absorbance detection at 270 nm, is described. The current method
has shown acceptable precision and adequate sensitivity for the
quantification of MLA. The method was successfully applied to
quantify the concentrations of MLA in D. malabaricum. Thus, it
can be concluded that reverse-phase HPLC method is adequate
to detect and quantify the alkaloids. The reverse-phase separation
may be preferred due to readily available columns, reduced solvent
use, and simplicity of the electrospray ionization source. The
method can thus be applied both to the measurement of MLA in
crude plant extracts and to isolated alkaloid samples in order to
determine the precise levels of any trace contamination with this
highly potent alkaloid prior to bioassay. Further studies are needed
to find other toxic and nontoxic alkaloids and to determine the toxicity and therapeutic potential of Delphinium malabaricum.
Acknowledgments
Authors are grateful to the Head, Department of Botany, Shivaji
University, Kolhapur. We are also thankful to Prof. N. S. Desai
and Mr. Subash Kudale for their extensive help. The financial
support received with gratitude from the University Grant
commission, New Delhi, is most appreciated.
Funding
The work was supported by University Grant commission, New
Delhi.
References
1. Dozortseva-Kubanova, P. M. The Pharmacology of the Alkaloid Methyllycaconitine (mellictine). Farmakologiia i toksikologiia 1959, 22, 3034.
1807
2. Mashkovskii, M. D. Medicinal Preparations [in Russian], Meditsina.
Moscow. 1984, 1, 265.
3. Clarke, P. B. S. The Fall and Rise of Neuronal a-Bungarotoxin Binding
Proteins. Trend. Pharm. Sci. 1992, 13, 407413.
4. Jacyno, J. M.; Harwood, J. S.; Lin, N. H.; Campbell, J. E.; Sullivan, J.
P.; Holladay, M. W. Lycaconitine Revisited: Partial Synthesis and Neuronal Nicotinic Acetylcholine Receptor Affinities. J. Natural Prod.
1996, 59, 707709.
5. Hardick, D. J.; Blagbrough, I. S.; Cooper, G.; Potter, B. V. L.;
Critchley, N.; Wonnacoth, S. A. Nudicauline and Elatineas Potent
Norditerpenoid Ligands at Rat Neuronal r-Bungarotoxin Binding
Sites: Importance of the 2- (Methylsuccinimido) benzoyl Moiety
for Neuronal Nicotinic Acetylcholine Receptor Binding. J. Med.
Chem. 1996, 39, 48604866.
6. Jennings, K. R.; Brown, D. G.; Wright, D. P. Methyllycaconitine, a
Naturally Occurring Insecticide with a High Affinity for the Insect
Cholinergic Receptor. Experientia 1986, 42 (6), 611613.
7. Harborne, J. B. Phytochemical Methods. Chapman and Hall, Ltd.:
London, 1973; 49188 pp.
8. Willaman, J. J.; Liu, H. L. Alkaloid-bearing plants and their contained
alkaloids. Lloydia (Supplement) 1970, 33, 180181.
9. Harbourne, J. B.; Baxter, H. Phytochemical Dictionary. London:
Taylor and Francis, 1993; 153 p.
10. Daniel, M. Medicinal Plants: Chemistry and Properties. Oxford and
IBH Publishing Co. Pvt. Ltd.: New Delhi, 2006; 230 p.
11. Facchini, P. J. Alkaloid Biosynthesis in Plants: Biochemistry,
Cell Biology, Molecular Regulation, and Metabolic Engineering
Applications. Ann. Rev. Plant Physiol. 2001, 52, 2966.
12. Benn, M. H. May J. The Biosynthesis of Diterpenoid Alkaloids.
Experientia 1964, 29, 252253.
13. Paterson, D.; Nordberg, A. Neuronal Nicotinic Receptors in the Human
Brain. Prog. Neurobiol. 2000, 61, 75111.
14. Unwin, N. Structure and action of the nicotinic acetylcholine receptor
explored by electron microscopy. FEBS Lett. 2003, Nov 27, 555 (1),
9195.
15. Albuquerque, E. X.; Pereira, E. F. R.; Alkondon, M.; Rogers, S. W.
Mammalian Nicotinic Acetylcholine Receptors: From Structure to
Function. Physiol. Rev. 2009, 89 (1), 73120.
16. Yunusov, M. S. Diterpenoid Alkaloids. Natural Prod. Rep. 1993, 10
(5), 471486.
17. Bergmeier, S. C.; Lapinsky, D. J.; Free, R. B.; McKay, D. B. Ring E
Analogs of Methyllycaconitine (MLA) as Novel Nicotinic Antagonists.
Bioorg. Med. Chem. Lett. 1999, 9 (15), 22632266.
18. Ward, J. M.; Cockcroft, V. B.; Lunt, G. G.; Smillie, F. S.; Wonnacott, S.
Methyllycaconitine: A Selective Probe for Neuronal Alphabungarotoxin Binding Sites. FEBS Lett. 1990, 270, 4548.
19. Macallan, D. R.; Lunt, G. G.; Wonnacott, S.; Swanson, K. L.; Rapoport,
H.; Albuquerque, E. X. Methyllycaconitine and ()-Anatoxin- a
Differentiate between Nicotinic Receptors in Vertebrate and
Invertebrate Nervous Systems. FEBS Lett. 1988, 226, 357363.
20. Yum, L.; Wolf, K. M.; Chiappinelli, V. A. Nicotinic Acetylcholine
Receptors in Separate Brain Regions Exhibit Different Affinities for
Methyllycaconitine. Neuroscience, 1996, 72 (2), 545555.
21. Davies, A. R. L.; Hardick, D. J.; Blagbrough, I. S.; Potter, B. V. L.;
Wolstenholme, A. J.; Wonnacott, S. Characterization of the binding
of [H-3]methyllycaconitine: A New Radioligand for Labelling Alpha
7-type Neuronal Nicotinic Acetylcholine Receptors. Neuropharmacology 1999, 38 (5), 679690.
22. Astles, P. C. B.; Boot, S. R.; Broad, J. R.; Dell, L. M.; Keenan, C. P.
Recent Progress in the Development of Subtype Selective Nicotinic
Acetylcholine Receptor Ligands. Curr. Drug Target. 2002, 1 (4),
337348.
23. Bergmeier, S. C.; Ismail, K. A.; Arason, K. M.; McKay, S.; Bryant,
D. L.; McKay, D. B. Structure Activity Studies of Ring E Analogues
of Methyllycaconitine. Part 2: Synthesis of Antagonists to the Alpha
3 Beta 4*Nicotinic Acetylcholine Receptors through Modifications
to the Ester. Bioorg. Med. Chem. Lett. 2004, 14 (14), 37393742.